Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Whitley

Showing results (461-470 of 489) with videos related to

Pageof 49
Sort By:
Journal of Virology|March 2, 2012
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12James M Markert, James J Cody, Jacqueline N Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2022
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB StudyKatherine E Miller, Kevin A Cassady, Justin C Roth, et al.
Science Advances|February 14, 2024
Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional propertiesMatthew J Whitley, Timothy H Tran, Megan Rigby, et al.
Theranostics|July 9, 2015
A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal TherapyYang Liu, Jeffrey R Ashton, Everett J Moding, et al.
Emerging Infectious Diseases|October 19, 2019
Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System DiseaseJohn W Gnann, Amy Agrawal, John Hart, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primatesJustin C Roth, Kevin A Cassady, James J Cody, et al.
The New England Journal of Medicine|August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge studyJohn P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
The Journal of Infectious Diseases|October 10, 2025
Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic StudyEdward P Acosta, Inmaculada Aban, Kevin J Ryan, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study GroupJ W Gnann, C S Crumpacker, J P Lalezari, et al.
Antiviral Chemistry & Chemotherapy|October 28, 2022
Meeting report: 34th international conference on antiviral researchAndrea Brancale, Kara Carter, Leen Delang, et al.
Pageof 49

Showing results (461-470 of 489) with videos related to

Sort By:
Pageof 49
Journal of Virology|March 2, 2012
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12James M Markert, James J Cody, Jacqueline N Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2022
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB StudyKatherine E Miller, Kevin A Cassady, Justin C Roth, et al.
Science Advances|February 14, 2024
Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional propertiesMatthew J Whitley, Timothy H Tran, Megan Rigby, et al.
Theranostics|July 9, 2015
A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal TherapyYang Liu, Jeffrey R Ashton, Everett J Moding, et al.
Emerging Infectious Diseases|October 19, 2019
Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System DiseaseJohn W Gnann, Amy Agrawal, John Hart, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primatesJustin C Roth, Kevin A Cassady, James J Cody, et al.
The New England Journal of Medicine|August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge studyJohn P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
The Journal of Infectious Diseases|October 10, 2025
Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic StudyEdward P Acosta, Inmaculada Aban, Kevin J Ryan, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study GroupJ W Gnann, C S Crumpacker, J P Lalezari, et al.
Antiviral Chemistry & Chemotherapy|October 28, 2022
Meeting report: 34th international conference on antiviral researchAndrea Brancale, Kara Carter, Leen Delang, et al.
Pageof 49